Ballot Measures to Mergers: California Stem Cell Agency Examines Alternatives to Its Demise

Sep 22, 2017

∙ Paid

Discussing the future of CIRM on Monday: Left to right, Chair Jonathan

Thomas, Vice chair Art Torres, Director Diane Winokur. Photos behind

them are of persons helped by the agency's clinical trials.

Photo by The California Stem Cell Report.

OAKLAND, Ca. -- Directors of California's $3 billion stem cell research effort are looking at ways to stave off…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.